Historical Stock Price
AKAO historical stock prices picture
AKAO (AKAO) has the following price history information. Looking back at AKAO historical stock prices for the last five trading days, on April 22, 2019, AKAO opened at $0.18, traded as high as $0.18 and as low as $0.15, and closed at $0.15. Trading volume was a total of 4.78M shares. On April 23, 2019, AKAO opened at $0.16, traded as high as $0.16 and as low as $0.13, and closed at $0.14. Trading volume was a total of 4.29M shares. On April 24, 2019, AKAO opened at $0.12, traded as high as $0.13 and as low as $0.10, and closed at $0.11. Trading volume was a total of 9.76M shares. On April 25, 2019, AKAO opened at $0.11, traded as high as $0.19 and as low as $0.10, and closed at $0.11. Trading volume was a total of 48.27M shares. On April 26, 2019, AKAO opened at $0.11, traded as high as $0.11 and as low as $0.11, and closed at $0.11. Trading volume was a total of 0 shares.

AKAO Historical Stock Prices By Date:

AKAO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AKAO shares, starting with a $10,000 purchase of AKAO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/26/2019
Start price/share: $13.93
End price/share: $0.11
Dividends collected/share: $0.00
Total return: -99.21%
Average Annual Total Return: -61.93%
Starting investment: $10,000.00
Ending investment: $78.92
Years: 5.01
Date Open High Low Close Volume
04/22/2019 $0.18 $0.18 $0.15 $0.15 4.78M
04/23/2019 $0.16 $0.16 $0.13 $0.14 4.29M
04/24/2019 $0.12 $0.13 $0.10 $0.11 9.76M
04/25/2019 $0.11 $0.19 $0.10 $0.11 48.27M
04/26/2019 $0.11 $0.11 $0.11 $0.11 0
Achaogen is a biopharmaceutical company engaged in discovering, developing, and commercializing antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. Co. develops plazomicin for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. Co. also develops antibacterial candidate, C-Scape, an orally-administered combination of ceftibuten and clavulanate for oral treatment for patients with cUTI, and acute pyelonephritis, caused by expanded spectrum beta-lactamases-producing Enterobacteriaceae.
Date Close
04/22/2019$0.15
04/23/2019$0.14
04/24/2019$0.11
04/25/2019$0.11
04/26/2019$0.11
AKAO is categorized under the Healthcare sector; below are some other companies in the same sector:

AKBA Historical Stock Prices
AKCA Historical Stock Prices
AKER Historical Stock Prices
AKRX Historical Stock Prices
ALBO Historical Stock Prices
ALC Historical Stock Prices
ALDR Historical Stock Prices
ALDX Historical Stock Prices
ALGN Historical Stock Prices
ALIM Historical Stock Prices

Also explore: AKAO shares outstanding history

Email EnvelopeFree AKAO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


AKAO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.